CMA POLICY

CMA Code of Ethics

3 24. Respect the right of a competent patient to accept or reject any medical care recommended. 25. Recognize the need to balance the developing

  Ethics

CMA POLICY

3 scientifically appropriate for drugs or devices relevant to their area of practice and where the study may contribute substantially to knowledge about the drug or device.

CMA POLICY SUMMARY

4 Canada, have information identifying physicians who specialize in assisting with the return to work. 7 In complex cases, the treating physician should consider referring the patient/employee to medical

  Policy, Physician

Introduction to Parenteral Preparations

to the patient. Disadvantages of parenteral preparations to the patient include lack of drug reversal, risk of infection and emboli, risk of hypersensitivity reactions, and cost.

  Patients

Drug-Resistant Tuberculosis: A Survival Guide for ...

TREATMENT Consultation with experts Treatment of tuberculosis (TB) caused by drug-resistant organisms should be done by, or in close consultation with, …

Treatment of Children With Chronic Hepatitis B Virus ...

MEETINGREPORT Treatment of Children With Chronic Hepatitis B Virus Infection in the United States: Patient Selection and Therapeutic Options Maureen M. Jonas,1 Joan M. Block,2 Barbara A. Haber,3 Saul J. Karpen,4 W. Thomas London,5 Karen F. Murray,6 Michael R. Narkewicz,7 Philip Rosenthal,8 Kathleen B. Schwarz,9 and Brian J. McMahon10 Chronic hepatitis B virus (HBV) infection in children ...

  States, Patients, Selection, Therapeutic, Options, Patient selection and therapeutic options

Radiation Protection Education in Fluoroscopy

512 CE Directed Reading RADOOGIC TECHNOOGY, May/June 2015, Volume 86, Number 5 Radiation Protection Education in Fluoroscopy the amount of radiation exposure children might receive

  Education, Protection, Radiation, Fluoroscopy, Radiation protection education in fluoroscopy

Final Concept Paper ICH Q3E: Guideline for Extractables ...

drug indication and patient exposure. The guidance will clarify how prior knowledge may be considered to determine the need for further safety studies. Where additional safety data are needed, a common strategy for obtaining these data will be developed. • Control options: This would include options to mitigate and control process-derived

  Patients, Options

TREATING BORDERLINE PERSONALITY DISORDER

transient mood states. • Consider introducing changes in treatment if the patient fails to show improvement in targeted goals by 6 to 12 months. • Consider consultation if the patient continues to do poorly after treatment is modified.

  States, Patients, Disorders, Personality, Borderline personality disorder, Borderline

Alternatives to the Indwelling Urinary Catheter

• Stop and think critically about whether the patient needs a urinary catheter or if there are alternatives that may be appropriate • Accurate intake and output can be achieved without the use of a urinary catheter • Educate staff on the use of alternatives and include staff in the trialing and selection process of alternatives. 24

  Patients, Selection, Catheter, Alternatives, Indwelling, Urinary, Alternatives to the indwelling urinary catheter

CDC Guideline for Prescribing Opioids for Chronic Pain ...

United States, although minimum duration of symptoms was not specified. Most recently, analysis of data from the 2012 . National Health Interview Study showed that 11.2% of adults report having daily pain (8). Clinicians should consider the full range of …

  Guidelines, States, Opioid, Prescribing, Chronic, Pain, Guideline for prescribing opioids for chronic pain

Clinical Decision Support: More than Just ‘Alerts’ Tipsheet

Parameter Guidance (e.g., displaying therapeutic ranges based on patient information on prescribing page, drug/dose pick-lists filtered by patient characteristics, and templates which require entry of all necessary documentation); Critiques and Warnings – “Immediate Alerts” (e.g., a pop-up warning if a provider enters a

  More, Than, Patients, Clinical, Just, Support, Decision, Therapeutic, More than just, Clinical decision support

Evidence Brief: Transcranial Magnetic Stimulation (TMS ...

patient safety and acceptability, it is reasonable to conclude that TMS therapy, in particular rTMS, could be considered a treatment option for patients who have exhausted other available options for treatment of chronic pain, PTSD, TBI, or opiate addiction. With this approach, a

  Patients, Options